Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments Life Science Investing
Cizzle Brands Places CWENCH Hydration and HappiEats Sport Pasta at 91 Popeye's Supplements Canada Locations Biotech Investing
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040 Biotech Investing
Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update Life Science Investing
Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update Life Science Investing
Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts Life Science Investing
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update Life Science Investing
Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc. Life Science Investing
NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close Life Science Investing
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update Life Science Investing
